KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Other Accumulated Expenses (2019 - 2022)

Biolife Solutions (BLFS) has disclosed Other Accumulated Expenses for 4 consecutive years, with $51000.0 as the latest value for Q4 2022.

  • Quarterly Other Accumulated Expenses rose 131.82% to $51000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $51000.0 through Dec 2022, up 131.82% year-over-year, with the annual reading at $51000.0 for FY2022, 131.82% up from the prior year.
  • Other Accumulated Expenses for Q4 2022 was $51000.0 at Biolife Solutions, up from $22000.0 in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $986000.0 in Q4 2019, with the low at $22000.0 in Q4 2021.
  • Average Other Accumulated Expenses over 4 years is $186400.0, with a median of $130000.0 recorded in 2020.
  • The sharpest move saw Other Accumulated Expenses crashed 86.82% in 2020, then soared 131.82% in 2022.
  • Over 4 years, Other Accumulated Expenses stood at $986000.0 in 2019, then crashed by 86.82% to $130000.0 in 2020, then crashed by 83.08% to $22000.0 in 2021, then soared by 131.82% to $51000.0 in 2022.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $51000.0, $22000.0, and $131000.0 for Q4 2022, Q3 2022, and Q2 2022 respectively.